Live feed
Filing
SC 13D/A
SC 13D/A0001104659-17-008135·Adamas Pharmaceuticals Inc
Schedule 13D ownership disclosure
ADAMAS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00548A106
Event date: 2016-09-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 46,197,962
- Percent of class
- 21.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-008135
- Form type
- SC 13D/A
- Filer
- Adamas Pharmaceuticals Inc
- CIK
- CIK 1328143
- Filed
- Feb 10, 2017
- Reporting period
- Sep 14, 2016
- Description
- Schedule 13D beneficial ownership